Jan-Willem J Lammers

Author PubWeight™ 100.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Management of lung nodules detected by volume CT scanning. N Engl J Med 2009 6.79
2 Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005 3.58
3 Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 2013 3.47
4 FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Biol 2002 2.86
5 Lung function decline in male heavy smokers relates to baseline airflow obstruction severity. Chest 2012 2.77
6 CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax 2011 2.20
7 Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. JAMA 2011 1.94
8 Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011 1.89
9 Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax 2011 1.82
10 Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction. Atherosclerosis 2013 1.69
11 Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail 2006 1.68
12 Results of surgical treatment of T4 non-small cell lung cancer. Eur J Cardiothorac Surg 2003 1.65
13 Computed tomography-quantified emphysema distribution is associated with lung function decline. Eur Respir J 2012 1.65
14 Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 2007 1.63
15 Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 2013 1.42
16 Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005 1.41
17 Effects of telemonitoring in patients with chronic obstructive pulmonary disease. Telemed J E Health 2008 1.41
18 Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir Med 2007 1.27
19 Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res 2011 1.27
20 The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules. Chest 2012 1.23
21 Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ 2006 1.22
22 Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up. Br J Gen Pract 2006 1.22
23 Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old. Fam Pract 2005 1.15
24 Early identification of small airways disease on lung cancer screening CT: comparison of current air trapping measures. Lung 2012 1.14
25 Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2. Blood 2005 1.13
26 Characterization of the role of CaMKI-like kinase (CKLiK) in human granulocyte function. Blood 2005 1.07
27 Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells. Blood 2002 1.06
28 Evaluation of Quality of Life instruments for use in COPD care and research: a systematic review. Int J Nurs Stud 2012 1.04
29 HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002 1.02
30 Src kinases regulate PKB activation and modulate cytokine and chemoattractant-controlled neutrophil functioning. J Leukoc Biol 2002 1.01
31 Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002 1.01
32 Expression of activated Fc gamma RII discriminates between multiple granulocyte-priming phenotypes in peripheral blood of allergic asthmatic subjects. J Allergy Clin Immunol 2007 0.99
33 Lung cancer screening CT-based prediction of cardiovascular events. JACC Cardiovasc Imaging 2013 0.99
34 Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur J Heart Fail 2007 0.98
35 Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening. Respir Res 2013 0.95
36 Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge. J Allergy Clin Immunol 2005 0.94
37 Role of Ca2+/calmodulin regulated signaling pathways in chemoattractant induced neutrophil effector functions. Comparison with the role of phosphotidylinositol-3 kinase. Eur J Biochem 2002 0.93
38 Treatment with inhaled corticosteroids in asthma is too often discontinued. Pharmacoepidemiol Drug Saf 2008 0.92
39 IL-5-mediated eosinophil survival requires inhibition of GSK-3 and correlates with beta-catenin relocalization. J Leukoc Biol 2006 0.91
40 Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT. BMC Pulm Med 2009 0.91
41 Perceived quality of life in chronic obstructive pulmonary disease patients: a cross-sectional study in primary care on the role of illness perceptions. BMC Fam Pract 2014 0.91
42 Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia. Clin Infect Dis 2007 0.91
43 Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study. Pharmacoepidemiol Drug Saf 2007 0.90
44 Human suppressive neutrophils CD16bright/CD62Ldim exhibit decreased adhesion. J Leukoc Biol 2012 0.90
45 Clinical utility of asthma biomarkers: from bench to bedside. Biologics 2013 0.90
46 Daily activities and health-related quality of life in patients with chronic obstructive pulmonary disease: psychological determinants: a cross-sectional study. Health Qual Life Outcomes 2013 0.90
47 Surgical treatment of Pancoast tumours. Eur J Cardiothorac Surg 2004 0.89
48 Expression of priming-associated cellular markers on neutrophils during an exacerbation of COPD. Respir Med 2006 0.89
49 Parametric response mapping adds value to current computed tomography biomarkers in diagnosing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015 0.88
50 Spirometric thresholds for diagnosing COPD: 0.70 or LLN, pre- or post-dilator values? COPD 2012 0.88
51 Platelets promote eosinophil adhesion of patients with asthma to endothelium under flow conditions. Am J Respir Cell Mol Biol 2003 0.88
52 Accuracy of symptoms, signs, and C-reactive protein for early chronic obstructive pulmonary disease. Br J Gen Pract 2012 0.87
53 Detecting exacerbations using the Clinical COPD Questionnaire. Health Qual Life Outcomes 2010 0.87
54 Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial. Eur J Cardiothorac Surg 2012 0.87
55 Association of chronic obstructive pulmonary disease and smoking status with bone density and vertebral fractures in male lung cancer screening participants. J Bone Miner Res 2014 0.86
56 Extent of uncontrolled disease and associated medical costs in severe asthma--a PHARMO study. Curr Med Res Opin 2008 0.84
57 Rate of progression of CT-quantified emphysema in male current and ex-smokers: a follow-up study. Respir Res 2013 0.84
58 The impact of heart failure on the classification of COPD severity. J Card Fail 2012 0.84
59 A Mobile Phone App to Stimulate Daily Physical Activity in Patients with Chronic Obstructive Pulmonary Disease: Development, Feasibility, and Pilot Studies. JMIR Mhealth Uhealth 2016 0.84
60 Are patient characteristics helpful in recognizing mild COPD (GOLD I) in daily practice? Scand J Prim Health Care 2006 0.83
61 Visual versus automated evaluation of chest computed tomography for the presence of chronic obstructive pulmonary disease. PLoS One 2012 0.82
62 Cytokine mediated suppression of TF-1 apoptosis requires PI3K activation and inhibition of Bim expression. FEBS Lett 2005 0.82
63 [Spontaneous pneumothorax as the first manifestation of a hereditary condition with an increased renal cancer risk]. Ned Tijdschr Geneeskd 2009 0.80
64 Quantification of right-to-left shunt with (99m)Tc-labelled albumin macroaggregates and 100% oxygen in patients with hereditary haemorrhagic telangiectasia. Clin Sci (Lond) 2002 0.80
65 Occupational endotoxin exposure reduces the risk of atopic sensitization but increases the risk of bronchial hyperresponsiveness. Int Arch Allergy Immunol 2009 0.80
66 Diffusing capacity for nitric oxide: reference values and dependence on alveolar volume. Respir Med 2007 0.80
67 How do COPD patients respond to exacerbations? BMC Pulm Med 2011 0.80
68 Variants in the 15q24/25 locus associate with lung function decline in active smokers. PLoS One 2013 0.80
69 The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial. J Thorac Oncol 2011 0.80
70 Can low-dose unenhanced chest CT be used for follow-up of lung nodules? AJR Am J Roentgenol 2012 0.79
71 Measuring exacerbations in obstructive lung disease. Pharmacoepidemiol Drug Saf 2010 0.79
72 Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis. J Am Acad Dermatol 2010 0.79
73 Relevant and redundant lung function parameters in discriminating asthma from COPD. COPD 2006 0.79
74 Pulmonary Nodule Volumetry at Different Low Computed Tomography Radiation Dose Levels With Hybrid and Model-Based Iterative Reconstruction: A Within Patient Analysis. J Comput Assist Tomogr 2016 0.78
75 Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD. COPD 2014 0.77
76 Genetic polymorphisms and bronchiolitis obliterans syndrome after lung transplantation: promising results and recommendations for the future. Transplantation 2012 0.77
77 A unique protein profile of peripheral neutrophils from COPD patients does not reflect cytokine-induced protein profiles of neutrophils in vitro. BMC Pulm Med 2011 0.77
78 Flow-volumes indices as means to discriminate between intra- and extrapulmonary restrictive disease. Respir Med 2005 0.77
79 A comparison of lung function equipment with emphasis on interchangeability and methods. Physiol Meas 2006 0.77
80 Computed tomography structural lung changes in discordant airflow limitation. PLoS One 2013 0.77
81 Hematocytometry analysis as discriminative marker for asthma phenotypes. Clin Chem Lab Med 2009 0.77
82 Discriminating asthma and COPD based on bronchodilator data: an improvement of the methods. Physiol Meas 2005 0.77
83 The Dutch functional performance inventory: validity and reliability in patients with chronic obstructive lung disease. Nurs Res 2014 0.76
84 Distinguishing patterns in the dynamics of long-term medication use by Markov analysis: beyond persistence. BMC Health Serv Res 2007 0.75
85 CT air trapping is independently associated with lung function reduction over time. PLoS One 2013 0.75
86 Longitudinal change of prebronchodilator spirometric obstruction. Thorax 2010 0.75
87 Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON study. Eur Radiol 2014 0.75
88 [A man with consolidation of the right lung]. Ned Tijdschr Geneeskd 2010 0.75
89 Analyzing bronchodilation with emphasis on disease type, age and sex. Control Clin Trials 2004 0.75
90 Functional analysis of the interleukin-5 receptor antagonist peptide, AF18748. Cytokine 2004 0.75
91 Effects of corticosteroid use on readmission in obstructive lung disease. Respir Med 2009 0.75
92 Aortic Valve and Thoracic Aortic Calcification Measurements: How Low Can We Go in Radiation Dose? J Comput Assist Tomogr 2017 0.75